Skip to content

Editors

Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Bill Steinman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Shruti J. Shah
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

World Bank follows DOJ by evaluating corporate compliance programs

The World Bank’s enforcement arm, the Integrity Vice Presidency (INT), signaled this month they are mirroring initiatives first put forth by U.S. law enforcement. Specifically, INT indicated that they are investing significant resources into formally evaluating companies’ compliance programs during an investigation.… Continue Reading

Do FOIA requests put journalists at risk?

Murdered Slovak journalist Jan Kuciak (credit Aktuality.sk)A 27-year-old Slovak reporter and his fiancée were murdered in their home in late February. It looked like a professional hit.

The journalist, Jan Kuciak, was working on an investigation for the Slovak news portal Aktuality.sk,… Continue Reading

Graft still stunts global development, UN says

Developing countries are losing between $20 billion to $40 billion every year, making graft the greatest obstacle to economic and social development around the world, according to a report released this month by the United Nations Office on Drugs and Crime (UNODC).… Continue Reading

Pfizer, Wyeth Pay $60 Million In Settlement

A subsidiary of Pfizer Inc. agreed with the DOJ today to pay a $15 million criminal penalty to resolve FCPA violations in Bulgaria, Croatia, Kazakhstan, and Russia.

Pfizer also agreed with the SEC to pay $26.3 million in disgorgement of profits and pre-judgment interest to settle civil charges.… Continue Reading

AZ Indicted For Bribery In Serbia

U.K.-based pharma AstraZeneca said its office in Belgrade, Serbia was served with a criminal indictment ‘relating to allegations that local employees . . . made allegedly improper payments to physicians at the Institute of Oncology and Radiology of Serbia.’ … Continue Reading